Immunocore announces re-organisation of its executive management to support business growth
Immunocore announces re-organisation of its executive management to support business growth
26 September 2014 at 11:00 AM EDT
Immunocore Limited, the biotechnology company developing novel biological drugs called ImmTACs, today announced a re-organisation of its executive management team. The changes are designed to support the continuing growth of Immunocore and its sister company, Adaptimmune. Both companies have recently experienced rapid growth based on encouraging clinical trials results.
Please click on the link below to download the full Press Release: